16-30 of 447
New Data From the CONFIDENCE Trial: The Effect of Combination Empagliflozin and Finerenone on UACR and eGFR in CKD and Type 2 Diabetes
NephrologyNew Data From the CONFIDENCE Trial: The Effect of Combination Empagliflozin and Finerenone on UACR and eGFR in CKD and Type 2 Diabetes
prof. Hiddo Heerspink
The Impact of Finerenone Plus Empagliflozin on Hyperkalemia in the CONFIDENCE Trial
NephrologyThe Impact of Finerenone Plus Empagliflozin on Hyperkalemia in the CONFIDENCE Trial
Rajiv Agarwal, MBBS, MD, FASN, BRCU
AIP Emerges as a Potential Marker for Diabetic Kidney Risk
Clinician's RoundtableAIP Emerges as a Potential Marker for Diabetic Kidney Risk
Pediatric Psoriasis in Focus: Emerging Insights on Immune and Obesity Drivers
On the Frontlines of PsoriasisPediatric Psoriasis in Focus: Emerging Insights on Immune and Obesity Drivers
Charles Turck, PharmD, BCPS, BCCCP
Amy Paller, MS, MD
Linking Obesity to Alzheimer’s: The Lipid Signals Driving Neurodegeneration
Clinician's RoundtableLinking Obesity to Alzheimer’s: The Lipid Signals Driving Neurodegeneration
Stephen Wong, PhD
Screening for Prediabetes in Youth with Obesity: Evaluating the TyG Index
Clinician's RoundtableScreening for Prediabetes in Youth with Obesity: Evaluating the TyG Index
Ryan Quigley
- advertisement
Obesity and Cancer Screening: National Trends and Disparities Revealed
Clinician's RoundtableObesity and Cancer Screening: National Trends and Disparities Revealed
Vance Albaugh, MD, PhD
Lifestyle Intervention and Bone Quality in Older Adults with Obesity
Clinician's RoundtableLifestyle Intervention and Bone Quality in Older Adults with Obesity
Identifying Hidden Risk: Metabolomic Patterns in Childhood Obesity
Clinician's RoundtableIdentifying Hidden Risk: Metabolomic Patterns in Childhood Obesity
EASD Highlights: Prediabetes Diagnosis, Prevalence, Misclassification Risks, and the Potential for Remission
Diabetes and EndocrinologyEASD Highlights: Prediabetes Diagnosis, Prevalence, Misclassification Risks, and the Potential for Remission
Femke Rutters, PhD
Managing Cholesterol and Triglyceride Levels: Targeted Nutritional Approaches
Heart MattersManaging Cholesterol and Triglyceride Levels: Targeted Nutritional Approaches
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Eye on Ocular HealthRisk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Marlene Mimi Maeusli, PhD.
- advertisement
PRP Scaffolds in Chronic Wound Care: A Move Toward Regenerative Solutions
Clinician's RoundtablePRP Scaffolds in Chronic Wound Care: A Move Toward Regenerative Solutions
Evaluating NIRF Imaging in Hard-to-Heal Lower Leg Wounds
Clinician's RoundtableEvaluating NIRF Imaging in Hard-to-Heal Lower Leg Wounds
Optimizing Outcomes in Diabetic Limb Preservation
Clinician's RoundtableOptimizing Outcomes in Diabetic Limb Preservation
Paul J. Kim, DPM, MS, FACFAS
